Shenyang KeChuang Technology Co., Ltd., established in 2007, is a comprehensive pharmaceutical enterprise specializing in the research, development, production, and sales of pharmaceutical intermediates. The company operates a trading subsidiary and possesses its own R&D center and production base. It has successfully developed and manufactured multiple products, including Febuxostat and its intermediates (such as Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylate), Dronedarone intermediates (such as 2-Butyl-5-nitrobenzofuran, 2-Butyl-3-(4-hydroxybenzoyl)-5-nitrobenzofuran, N-(3-Chloropropyl)dibutylamine), Agomelatine intermediates, Perindopril intermediates (such as L-Norvaline), and Aliskiren intermediates. Currently, the company serves as a long-term supplier for numerous multinational pharmaceutical corporations in Europe, the United States, India, and other countries, providing customized synthesis of patented drugs and pharmaceutical intermediates, as well as supporting services for industrial-scale production. Its products are sold worldwide, earning a strong reputation and corporate image.

The company boasts robust scientific research and innovation capabilities, having established long-term collaborations with several renowned domestic drug research institutions. It has set up an R&D center and introduces new, market-driven, high-tech products annually.

Adhering to the operational principle that "product quality is the foundation of enterprise survival and development," KeChuang Technology ensures that its products and services comply with continuously updated domestic and international standards through effective process control and systematic quality management. We are committed to providing high-quality, efficient services with superior products and competitive prices, striving to become your sincere and trustworthy partner.